A PHASE III RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF PRM-151 IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS

Authors
Category Primary study
Registry of TrialsClinical Trials Peruvian Registry
Year 2021
This article has no abstract
Epistemonikos ID: 8c044315be310670b968e837e17223abeae37a46
First added on: Apr 11, 2025